Format

Send to

Choose Destination
Nature. 2019 Jan;565(7738):E5-E6. doi: 10.1038/s41586-018-0722-x.

Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Author information

1
The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
3
Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.
4
Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA.
5
Sage Bionetworks, 1100 Fairview Ave. N., Seattle, Washington, 98109, USA.
6
Genomics Institute of the Novartis Research Foundation, San Diego, California, 92121, USA.
7
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
8
Novartis Institutes for Biomedical Research, Emeryville, California, 94608, USA.
9
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
10
Howard Hughes Medical Institute, Chevy Chase, Maryland, 20815, USA.
11
Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, 02139, USA. robert.schlegel@novartis.com.
12
The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, 02142, USA. Levi_Garraway@dfci.harvard.edu.
13
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
14
Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. Levi_Garraway@dfci.harvard.edu.
PMID:
30559381
DOI:
10.1038/s41586-018-0722-x

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center